Researcher Justin Kander asked the doctors’ panel at the recent “State of Marijuana” forum which peer-reviewed journal articles they cited to validate their recommending cannabis to patients. Here’s the list, with the Kiehl study on schizophrenia TK. Thanks to Kander for the question and now the answers, with links. Versions of some of these papers were published in O’Shaughnessy’s. We’re adding them to the list of respectable journal articles, inspired by this correspondence from John McPartland.
• Endocannabinoid System as an Emerging Target of Pharmacotherapy (ECS plays a role in virtually every major disease.)
• Human Cannabinoid Pharmacokinetics (bioavailability of different routes of administration)
• Care and Feeding of the Endocannabinoid System (ways to naturally upregulate your endocannabinoid system). John McPartland first published a piece with this title in O’Shaughnessy’s. But this piece didn’t count.
• This is Dr. Donald Tashkin’s original study showing that smoking cannabis doesn’t increase one’s risk for lung cancer. Tashkin first announced his findings at the 2005 International Cannabinoid Research Society symposium, as reported here. We also ran a piece about how Tashkin’s blockbuster study got buried.
• Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol (Why whole-plant CBD is better than CBD isolate; much more predictable and effective responses. Only abstract available at present. Martin Lee’s take on it will run in the new O’Shaughnessy’s.
• Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival (How THC and CBD work together to fight brain cancer). The account of Sean McAllister’s work starts on page 1 of O’Shaughnessy’s 2009 edition and jumps to page 19.
Tracy Ryan had also mentioned an observational study by United Patients Group about treating different forms of breast cancer. However, that link for some reason is down.